Search

George R. Fourson Iii

Examiner (ID: 18379, Phone: (571)272-1860 , Office: P/2823 )

Most Active Art Unit
2823
Art Unit(s)
2823, 1104, 2814, 2899, 1107, 1106
Total Applications
2346
Issued Applications
2005
Pending Applications
21
Abandoned Applications
325

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18158939 [patent_doc_number] => 20230025531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => Novel Isoquinoline Derivative, Preparing Method Thereof, and Pharmaceutical Composition for Preventing or Treating Autophagy Related Diseases Containing the Same as an Active Ingredient [patent_app_type] => utility [patent_app_number] => 17/367254 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12514 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367254 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/367254
Isoquinoline derivative, preparing method thereof, and pharmaceutical composition for preventing or treating autophagy related diseases containing the same as an active ingredient Jul 1, 2021 Issued
Array ( [id] => 18565676 [patent_doc_number] => 20230256003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS CONTAINING FUNCTIONALIZED TRANSITION METAL DICHALCOGENIDE [patent_app_type] => utility [patent_app_number] => 18/009665 [patent_app_country] => US [patent_app_date] => 2021-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8649 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009665 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/009665
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS CONTAINING FUNCTIONALIZED TRANSITION METAL DICHALCOGENIDE Jun 23, 2021 Pending
Array ( [id] => 18268208 [patent_doc_number] => 20230089450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => DISILVER HYDROGEN CITRATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, ANTIBACTERIAL AGENT OR ANTIVIRAL AGENT USING SAME, AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 17/799059 [patent_app_country] => US [patent_app_date] => 2021-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799059 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/799059
DISILVER HYDROGEN CITRATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, ANTIBACTERIAL AGENT OR ANTIVIRAL AGENT USING SAME, AND METHOD FOR PRODUCING SAME Jun 21, 2021 Pending
Array ( [id] => 18707460 [patent_doc_number] => 20230330034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS SYSTEMS FOR THE DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULES [patent_app_type] => utility [patent_app_number] => 18/002897 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002897 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002897
COVALENTLY CROSS-LINKED GLYCOSYLATED MUCIN NANOPARTICLES AS SYSTEMS FOR THE DELIVERY AND RELEASE OF ACTIVE INGREDIENTS AND BIOMOLECULES Jun 20, 2021 Pending
Array ( [id] => 18550652 [patent_doc_number] => 20230248652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => BIODEGRADEABLE MULTI-CAVITY MICROPARTICLES AND THEIR USE IN TREATMENT [patent_app_type] => utility [patent_app_number] => 18/010219 [patent_app_country] => US [patent_app_date] => 2021-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010219 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/010219
BIODEGRADEABLE MULTI-CAVITY MICROPARTICLES AND THEIR USE IN TREATMENT Jun 15, 2021 Pending
Array ( [id] => 18707651 [patent_doc_number] => 20230330230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => SENSITISER FOR CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 18/001843 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001843 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001843
SENSITISER FOR CANCER TREATMENT Jun 13, 2021 Abandoned
Array ( [id] => 17183729 [patent_doc_number] => 20210330614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/343169 [patent_app_country] => US [patent_app_date] => 2021-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10828 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17343169 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/343169
PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS Jun 8, 2021 Abandoned
Array ( [id] => 18436181 [patent_doc_number] => 20230183475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR [patent_app_type] => utility [patent_app_number] => 17/923945 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46857 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923945 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923945
GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR May 11, 2021 Pending
Array ( [id] => 19246925 [patent_doc_number] => 20240197909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS [patent_app_type] => utility [patent_app_number] => 17/998318 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15165 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998318 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998318
NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS May 11, 2021 Abandoned
Array ( [id] => 17719196 [patent_doc_number] => 20220211915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => SURGICAL SYSTEM AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/306053 [patent_app_country] => US [patent_app_date] => 2021-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20096 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306053 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/306053
Surgical system and methods of use May 2, 2021 Issued
Array ( [id] => 18565731 [patent_doc_number] => 20230256058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => LOW BURST-RELEASE LIRAGLUTIDE DEPOT SYSTEMS [patent_app_type] => utility [patent_app_number] => 18/001610 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14300 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001610 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001610
LOW BURST-RELEASE LIRAGLUTIDE DEPOT SYSTEMS Apr 25, 2021 Abandoned
Array ( [id] => 17911191 [patent_doc_number] => 20220313586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => COSMETIC COMPOSITION WITH GLAUCINE, RETINOL AND PEPTIDES TO COMBAT SKIN AGING [patent_app_type] => utility [patent_app_number] => 17/218960 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9960 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218960 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/218960
COSMETIC COMPOSITION WITH GLAUCINE, RETINOL AND PEPTIDES TO COMBAT SKIN AGING Mar 30, 2021 Abandoned
Array ( [id] => 18295913 [patent_doc_number] => 20230105599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => Aqueous Formulations Containing Povidone Iodine for Effective Treatment and Prevention of Virus Infections [patent_app_type] => utility [patent_app_number] => 17/281553 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7323 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281553 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/281553
Aqueous Formulations Containing Povidone Iodine for Effective Treatment and Prevention of Virus Infections Mar 28, 2021 Pending
Array ( [id] => 17124265 [patent_doc_number] => 20210299033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => COMPOSITIONS COMPRISING CARUM CARVI AND ROSMARINUS OFFICINALIS EXTRACTS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/210747 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9802 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210747 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/210747
COMPOSITIONS COMPRISING CARUM CARVI AND ROSMARINUS OFFICINALIS EXTRACTS AND METHODS OF USING SAME Mar 23, 2021 Abandoned
Array ( [id] => 17124271 [patent_doc_number] => 20210299039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY CONTACT LENS MEDIATED DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 17/209645 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209645 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/209645
COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY CONTACT LENS MEDIATED DRUG DELIVERY Mar 22, 2021 Abandoned
Array ( [id] => 17109930 [patent_doc_number] => 20210290527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => Compositions and Methods for Treatment of Ocular Conditions [patent_app_type] => utility [patent_app_number] => 17/208381 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5568 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208381 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/208381
Compositions and Methods for Treatment of Ocular Conditions Mar 21, 2021 Abandoned
Array ( [id] => 17213242 [patent_doc_number] => 20210346578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => DEVICE AND METHOD FOR TREATING INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/207337 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4894 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207337 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/207337
DEVICE AND METHOD FOR TREATING INFECTIONS Mar 18, 2021 Abandoned
Array ( [id] => 17124541 [patent_doc_number] => 20210299309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => TENT WITH ANTIMICROBIAL TREATMENT APPLIED THERETO AND METHOD OF IMPARTING ANTIMICROBIAL PROPERTIES TO THE TENT [patent_app_type] => utility [patent_app_number] => 17/205630 [patent_app_country] => US [patent_app_date] => 2021-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1885 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205630 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/205630
TENT WITH ANTIMICROBIAL TREATMENT APPLIED THERETO AND METHOD OF IMPARTING ANTIMICROBIAL PROPERTIES TO THE TENT Mar 17, 2021 Abandoned
Array ( [id] => 17095266 [patent_doc_number] => 20210283057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => SUSTAINED-RELEASE PARTICLES AND PRODUCTION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/199518 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23237 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199518 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/199518
SUSTAINED-RELEASE PARTICLES AND PRODUCTION METHOD THEREOF Mar 11, 2021 Abandoned
Array ( [id] => 17095521 [patent_doc_number] => 20210283312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => BIOMIMETIC ELECTRICALLY CONDUCTIVE HYALURONIC ACID-BASED HYDROGELS [patent_app_type] => utility [patent_app_number] => 17/198211 [patent_app_country] => US [patent_app_date] => 2021-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7877 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198211 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/198211
Biomimetic electrically conductive hyaluronic acid-based hydrogels Mar 9, 2021 Issued
Menu